LONDON, March 21, 2018 -- According to this latest publication from Meticulous Research™, NGS services market to reach USD 2,921.4 million by 2023, growing at a CAGR of 20.1% during the forecast period of 2018 to 2023. “Plummeting cost of sequencing, growing need of skilled professionals for efficient NGS sample preparation and analysis, technological advancements, increase in genome mapping programs, and high cost of sequencing infrastructure are the major factors driving the growth of NGS services market”, mentions Meticulous Research™.
The report also notes that, “growing application of NGS technology in cancer and agrigenomics research for the analysis of complex sequencing data and rising demand for personalized medicine provides significant opportunities to NGS service providers.”
Request Sample Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=3875
Geographically, North America dominated the global NGS services market in 2017, mainly due to the increasing burden of chronic and infectious diseases, growing R&D expenditure, various government initiatives, and the presence of many services providers in this region.
The key players in the global NGS services market are Illumina, Inc., Qiagen N.V., PerkinElmer, Inc., Eurofins Scientific SE, GATC Biotech AG, Macrogen, Inc., Genotypic Technology Pvt. Ltd., GENEWIZ, Inc., Beijing Genomics Institute, SciGenom Labs Pvt. Ltd., MedGenome, DNA Link, Inc., Otogenetics Corporation, Novogene Corporation, LGC Limited, CD Genomics, and SeqLL, LLC.
Full News: https://www.meticulousresearch.com/next-generation-sequencing-ngs-services-market-2023/
Scope of the Report:
Market by Service Type:
- Targeted Sequencing
- RNA Sequencing
- Exome Sequencing
- De Novo Sequencing
- ChIP-Sequencing
- Whole Genome Sequencing
- Methyl Sequencing
- Other Services
Market by Technology:
- Sequencing by Synthesis (SBS)
- Ion Semiconductor Sequencing (IOS)
- Single Molecule Real Time Sequencing (SMRT)
- Nanopore Sequencing
- True Single Molecule Sequencing (tSMS)
Market by Application:
- Diagnostics
- Drug Discovery
- Biomarker Discovery
- Agriculture & Animal Research
- Other Applications
Market by End User:
- Academic & Research Institutes
- Pharmaceuticals & Biotechnology Industry
- Hospitals & Clinics
- Other End Users
Market by Geography:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Browse in-depth report here: https://www.meticulousresearch.com/product/next-generation-sequencing-ngs-services-market/
Contact Info:
Viren Shrivastava
Email: [email protected]
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)


Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Samsung Electronics Shares Jump on HBM4 Mass Production Report
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Anta Sports Expands Global Footprint With Strategic Puma Stake
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



